• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter: Daunomycin (NSC-82151) and adriamycin (NSC-123127): a hypothesis concerning antitumor activity and cardiotoxicity.

作者信息

Adamson R H

出版信息

Cancer Chemother Rep. 1974 May-Jun;58(3):293-4.

PMID:4841712
Abstract
摘要

相似文献

1
Letter: Daunomycin (NSC-82151) and adriamycin (NSC-123127): a hypothesis concerning antitumor activity and cardiotoxicity.
Cancer Chemother Rep. 1974 May-Jun;58(3):293-4.
2
Another hypothesis concerning the antitumor activity and cardiotoxicity of daunorubicin (NSC-82151) and adriamycin (NSC-123127).
Cancer Chemother Rep. 1975 Mar-Apr;59(2 Pt 1):258-9.
3
The cardiotoxicity of adriamycin and daunomycin in children.阿霉素和柔红霉素对儿童的心脏毒性。
Cancer. 1976 Feb;37(2 Suppl):1070-8. doi: 10.1002/1097-0142(197602)37:2+<1070::aid-cncr2820370814>3.0.co;2-6.
4
Enhancement of antitumor effectiveness of ICRF-159 (NSC-129943) against early L1210 leukemia by combination with cis-diamminedichloroplatinum (NSC-119875) or daunomycin (NSC-82151).通过与顺二氨二氯铂（NSC - 119875）或柔红霉素（NSC - 82151）联合使用增强ICRF - 159（NSC - 129943）对早期L1210白血病的抗肿瘤效果。
Cancer Chemother Rep 2. 1974 Mar;4(1):45-52.
5
[Cardiotoxicity of anthracycline cytostatic agents--a proposal for routine monitoring and supportive therapy].[蒽环类细胞毒性药物的心脏毒性——常规监测及支持治疗建议]
Vnitr Lek. 1991 Feb;37(2):151-9.
6
Editorial: Adriamycin and the heart.
Lancet. 1974 Jun 29;1(7870):1325.
7
Toxicologic screening of daunorubicin (NSC-82151), adriamycin (NSC-123127), and their derivatives in rats.
Cancer Chemother Rep. 1975 Jul-Aug;59(4):707-15.
8
On the reported lack of effectiveness of daunomycin (NSC-82151) and adriamycin (NSC-123127) on solid tumors.
Cancer Chemother Rep. 1972 Aug;56(4):431-2.
9
Daunomycin- and adriamycin-N-(2-hydroxypropyl)methacrylamide copolymer conjugates; toxicity reduction by improved drug-delivery.柔红霉素和阿霉素 - N -（2 - 羟丙基）甲基丙烯酰胺共聚物缀合物；通过改善药物递送降低毒性
Cancer Treat Rev. 1987 Dec;14(3-4):319-27. doi: 10.1016/0305-7372(87)90024-7.
10
Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors.
Cancer Chemother Rep. 1974 Sep-Oct;58(5 Pt 1):671-6.

引用本文的文献

1
Cancer chemotherapy: new developments and changing concepts.癌症化疗：新进展与观念转变
Drugs. 1980 Nov;20(5):375-97. doi: 10.2165/00003495-198020050-00003.
2
Detection and quantification of mitoxantrone in human organs. A case report.人器官中米托蒽醌的检测与定量。病例报告。
Cancer Chemother Pharmacol. 1984;13(1):67-8. doi: 10.1007/BF00401451.
3
A phase I trial of ametantrone acetate (NSC-287513).醋酸氨茴环素（NSC-287513）的I期试验。
Invest New Drugs. 1985;3(4):383-8. doi: 10.1007/BF00170762.
4
Mitoxantrone: an overview of safety and toxicity.米托蒽醌：安全性与毒性概述
Invest New Drugs. 1985;3(2):123-32. doi: 10.1007/BF00174159.
5
Structural modification study of anthracyclinones: synthesis and biological activity of several derivatives of eta-pyrromycinone.
Pharm Res. 1992 Jun;9(6):739-42. doi: 10.1023/a:1015891102895.
6
Cardiotoxic effects of antitumor agents.抗肿瘤药物的心脏毒性作用。
Cancer Chemother Pharmacol. 1978;1(1):24-34. doi: 10.1007/BF00253143.
7
Anthracyclines--modern tumour-inhibiting agents.
Folia Microbiol (Praha). 1978;23(2):152-61. doi: 10.1007/BF02915316.
8
Antineoplastic drugs: clinical pharmacology and therapeutic use.抗肿瘤药物：临床药理学与治疗应用
Drugs. 1978 Jul;16(1):46-87. doi: 10.2165/00003495-197816010-00003.